Table 1.
First author, year | FT3 | FT4 | TSH |
---|---|---|---|
Ando S, 2001-1 | NA | 7.4 ng/dl (0.9-1.6) | 10.5 μU/ml (0.43-4.60) |
Ando S, 2001-2 | NA | 1.7 ng/dl (0.9-1.6) | 121.6 μU/ml (0.43-4.60) |
Safer JD, 2001 | 606 pg/dl (210-440) | 2.6 ng/dl (0.8-2.7) | 0.4 mIU/L (0.3-5.0) |
Kong AP, 2005 | 9.65-12.3 pmol/L (3.28-8.2) | 20.7 pmol/L (8.5-20.7) | 16.7 mIU/L (0.3-4.0) |
Teng X, 2015 | 14.25 pmol/L (2.63-5.7) | 28.79 pmol/L (9.01-19.05) | 21.11 mIU/L (0.35-4.94) |
Ramos-Leví AM, 2016 | 7.32 pg/ml (2.5-3.9) | 2.2 ng/dl (0.8-1.7) | 10.5 μU/ml (0.3-5.6) |
Sriphrapradang C, 2016 | NA | 13.9 (6-11.5) | 2.8 mU/L (0.4-3.6) |
Ramos LS, 2018 | NA | 2.8 ng/dl (0.6-1.5) | 1.5 mIU/L (0.3-4.0) |
NA | 2.9 ng/dl (0.6-1.5) | 6.7 mIU/L (0.3-4.0) | |
Yu C, 2018 | 9.76 pg/ml (4.1-7.9) | 26.78 pg/ml (12-22) | 5.21 μIU/ml (0.27-4.2) |
Carvalho Cunha N, 2019 | NA | 2.1 pg/dl (0.8-1.9) | 9.6 μIU/ml (0.4-4.0) |
Jiaqi L, 2019 | NA | 56.7-70.7 pmol/L (12.0-22.0) | 4.85-10.93 mU/L (0.27-4.20) |
NA | 32.34-32.09 pmol/L (12.0-22.0) | 10.73-26.34 mU/L (0.27-4.20) | |
Campi I, 2020 | 8.13 pmol/L (4.2-7.5) | 35.3 pmol/L (10-20) | 1.3 μIU/ml (0.3-5.1) |
6.9 pmol/L (4.2-7.5) | 26.8 pmol/L (10-20) | 1.58 μIU/ml (0.3-5.1) | |
Suntornlohanakul O, 2022 | 3.14 pg/ml (2-4.4) | 2.09 ng/dl (0.7-1.75) | 7.27 mIU/L (0.25-4) |
FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; NA, not available.